Results 1 to 10 of about 1,537,610 (110)

Hemolytic Uremic Syndrome Outbreak in Adults and Shiga Toxin–Producing Escherichia coli Negative for Locus of Enterocyte Effacement, France, 2025

open access: yesEmerging Infectious Diseases
In January 2025, the Escherichia coli National Reference Center of France detected an outbreak of hemolytic uremic syndrome (HUS) in adults, caused by Shiga toxin–producing E. coli negative for locus of enterocyte effacement (LEE). The outbreak included
Justine de Larminat   +16 more
doaj   +1 more source

Zoonotic Escherichia coli

open access: yesActa Veterinaria Scandinavica, 2002
Escherichia coli is a normal inhabitant of the gastrointestinal tract of all warm-blooded animals, but variants of this species is also among the important etiological agents of enteritis and several extraintestinal diseases. The E.
Wasteson Yngvild
doaj   +1 more source

Whole Genome Sequencing of an Unusual Serotype of Shiga Toxin–producing Escherichia coli

open access: yesEmerging Infectious Diseases, 2013
Shiga toxin–producing Escherichia coli serotype O117:K1:H7 is a cause of persistent diarrhea in travelers to tropical locations. Whole genome sequencing identified genetic mechanisms involved in the pathoadaptive phenotype.
Tim Dallman   +6 more
doaj   +1 more source

Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype

open access: yesScientific Reports, 2018
Shiga toxin (Stx) is the key virulent factor in Shiga toxin-producing Escherichia coli (STEC). To date, three Stx1 subtypes and seven Stx2 subtypes have been described in E. coli, which differed in receptor preference and toxin potency.
Xiangning Bai   +8 more
doaj   +1 more source

Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis

open access: yesLife Science Alliance, 2019
This study reports an unexpected role of late endosome–lysosome fusion in early endosome-to-Golgi trafficking of Shiga toxins and identifies tamoxifen to be a potent inhibitor of Shiga toxicosis. Shiga toxin 1 (STx1) and 2 (STx2), produced by Shiga toxin–
Andrey S Selyunin   +3 more
doaj   +1 more source

Isolation of Shiga toxin-producing Escherichia coli from raw milk in Kermanshah, Iran

open access: yesIranian Journal of Microbiology, 2013
Background and Objectives: Infectious diarrhoeal diseases are great problem throughout the world and are responsible for considerable morbidity and mortality.
Pantea Mohammadi   +3 more
doaj  

Aplikasi Kandidat Pemindai untuk Diagnosis Gen Shiga like toxin-2 dari Escherichia coli O157:H7 (PROBE APLICATION TO DIAGNOSTIC PROGRAME OF SHIGA LIKE TOXIN-2 (STX2) GEN FROM ESCHERICHIA COLI O157:H7)

open access: yesJurnal Veteriner, 2013
A Shiga-like toxin producing Escherichia coli O157:H7 has been detected in cattle fecal sample, atbeef, and human as well as in beef and indicating that the agent is a harmful zoonosis bacteria. Geneticanalysis of Shiga toxin Escherichia coli (STEC) gene
I Wayan Suardana   +2 more
doaj  

Shiga Toxin–producing Escherichia coli, Idaho

open access: yesEmerging Infectious Diseases, 2007
Vivian Marie Lockary   +2 more
doaj   +1 more source

Primary Thrombotic Microangiopathy in Pediatric Patients

open access: yesGlobal Pediatric Health
Background . Primary thrombotic microangiopathy includes hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli , atypical hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Methodology .
Andrés David Aranzazu Ceballos MD   +5 more
doaj   +1 more source

Shiga Toxin–Producing Escherichia coli O157:H7 in Japan

open access: yesEmerging Infectious Diseases, 1999
Jun Terajima   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy